Drug resistance mechanisms and novel drug targets for tuberculosis therapy

Md Mahmudul Islam, H. M Adnan Hameed, Julius Mugweru, Chiranjibi Chhotaray, Changwei Wang, Yaoju Tan, Jianxiong Liu, Xinjie Li, Shouyong Tan, Iwao Ojima, Wing Wai Yew, Eric Nuermberger, Gyanu Lamichhane, Tianyu Zhang

Research output: Contribution to journal › Review article

Abstract

Drug-resistant tuberculosis (TB) poses a significant challenge to the successful treatment and control of TB worldwide. Resistance to anti-TB drugs has existed since the beginning of the chemotherapy era. New insights into the resistant mechanisms of anti-TB drugs have been provided. Better understanding of drug resistance mechanisms helps in the development of new tools for the rapid diagnosis of drug-resistant TB. There is also a pressing need in the development of new drugs with novel targets to improve the current treatment of TB and to prevent the emergence of drug resistance in Mycobacterium tuberculosis. This review summarizes the anti-TB drug resistance mechanisms, furnishes some possible novel drug targets in the development of new agents for TB therapy and discusses the usefulness using known targets to develop new anti-TB drugs. Whole genome sequencing is currently an advanced technology to uncover drug resistance mechanisms in M. tuberculosis. However, further research is required to unravel the significance of some newly discovered gene mutations in their contribution to drug resistance.

LanguageEnglish (US)
Pages21-37
Number of pages17
JournalJournal of Genetics and Genomics
Volume44
Issue number1
DOIs
StatePublished - Jan 20 2017

Fingerprint

Drug Resistance
Tuberculosis
Pharmaceutical Preparations
Multidrug-Resistant Tuberculosis
Mycobacterium tuberculosis
Therapeutics
Genome
Technology
Drug Therapy
Mutation
Research
Genes

Keywords

  • Drug target
  • Mechanism
  • Mycobacterium tuberculosis
  • Resistance
  • Tuberculosis

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Islam, M. M., Hameed, H. M. A., Mugweru, J., Chhotaray, C., Wang, C., Tan, Y., ... Zhang, T. (2017). Drug resistance mechanisms and novel drug targets for tuberculosis therapy. Journal of Genetics and Genomics, 44(1), 21-37. DOI: 10.1016/j.jgg.2016.10.002

Drug resistance mechanisms and novel drug targets for tuberculosis therapy. / Islam, Md Mahmudul; Hameed, H. M Adnan; Mugweru, Julius; Chhotaray, Chiranjibi; Wang, Changwei; Tan, Yaoju; Liu, Jianxiong; Li, Xinjie; Tan, Shouyong; Ojima, Iwao; Yew, Wing Wai; Nuermberger, Eric; Lamichhane, Gyanu; Zhang, Tianyu.

In: Journal of Genetics and Genomics, Vol. 44, No. 1, 20.01.2017, p. 21-37.

Research output: Contribution to journal › Review article

Islam, MM, Hameed, HMA, Mugweru, J, Chhotaray, C, Wang, C, Tan, Y, Liu, J, Li, X, Tan, S, Ojima, I, Yew, WW, Nuermberger, E, Lamichhane, G & Zhang, T 2017, 'Drug resistance mechanisms and novel drug targets for tuberculosis therapy' Journal of Genetics and Genomics, vol 44, no. 1, pp. 21-37. DOI: 10.1016/j.jgg.2016.10.002
Islam MM, Hameed HMA, Mugweru J, Chhotaray C, Wang C, Tan Y et al. Drug resistance mechanisms and novel drug targets for tuberculosis therapy. Journal of Genetics and Genomics. 2017 Jan 20;44(1):21-37. Available from, DOI: 10.1016/j.jgg.2016.10.002
Islam, Md Mahmudul ; Hameed, H. M Adnan ; Mugweru, Julius ; Chhotaray, Chiranjibi ; Wang, Changwei ; Tan, Yaoju ; Liu, Jianxiong ; Li, Xinjie ; Tan, Shouyong ; Ojima, Iwao ; Yew, Wing Wai ; Nuermberger, Eric ; Lamichhane, Gyanu ; Zhang, Tianyu. / Drug resistance mechanisms and novel drug targets for tuberculosis therapy. In: Journal of Genetics and Genomics. 2017 ; Vol. 44, No. 1. pp. 21-37
@article{19e52d3b042d4d6b9e1bd720fad4af78,
title = "Drug resistance mechanisms and novel drug targets for tuberculosis therapy",
abstract = "Drug-resistant tuberculosis (TB) poses a significant challenge to the successful treatment and control of TB worldwide. Resistance to anti-TB drugs has existed since the beginning of the chemotherapy era. New insights into the resistant mechanisms of anti-TB drugs have been provided. Better understanding of drug resistance mechanisms helps in the development of new tools for the rapid diagnosis of drug-resistant TB. There is also a pressing need in the development of new drugs with novel targets to improve the current treatment of TB and to prevent the emergence of drug resistance in Mycobacterium tuberculosis. This review summarizes the anti-TB drug resistance mechanisms, furnishes some possible novel drug targets in the development of new agents for TB therapy and discusses the usefulness using known targets to develop new anti-TB drugs. Whole genome sequencing is currently an advanced technology to uncover drug resistance mechanisms in M. tuberculosis. However, further research is required to unravel the significance of some newly discovered gene mutations in their contribution to drug resistance.",
keywords = "Drug target, Mechanism, Mycobacterium tuberculosis, Resistance, Tuberculosis",
author = "Islam, {Md Mahmudul} and Hameed, {H. M Adnan} and Julius Mugweru and Chiranjibi Chhotaray and Changwei Wang and Yaoju Tan and Jianxiong Liu and Xinjie Li and Shouyong Tan and Iwao Ojima and Yew, {Wing Wai} and Eric Nuermberger and Gyanu Lamichhane and Tianyu Zhang",
year = "2017",
month = "1",
day = "20",
doi = "10.1016/j.jgg.2016.10.002",
language = "English (US)",
volume = "44",
pages = "21--37",
journal = "Journal of Genetics and Genomics",
issn = "1673-8527",
publisher = "Institute of Genetics and Developmental Biology",
number = "1",

}

TY - JOUR

T1 - Drug resistance mechanisms and novel drug targets for tuberculosis therapy

AU - Islam,Md Mahmudul

AU - Hameed,H. M Adnan

AU - Mugweru,Julius

AU - Chhotaray,Chiranjibi

AU - Wang,Changwei

AU - Tan,Yaoju

AU - Liu,Jianxiong

AU - Li,Xinjie

AU - Tan,Shouyong

AU - Ojima,Iwao

AU - Yew,Wing Wai

AU - Nuermberger,Eric

AU - Lamichhane,Gyanu

AU - Zhang,Tianyu

PY - 2017/1/20

Y1 - 2017/1/20

N2 - Drug-resistant tuberculosis (TB) poses a significant challenge to the successful treatment and control of TB worldwide. Resistance to anti-TB drugs has existed since the beginning of the chemotherapy era. New insights into the resistant mechanisms of anti-TB drugs have been provided. Better understanding of drug resistance mechanisms helps in the development of new tools for the rapid diagnosis of drug-resistant TB. There is also a pressing need in the development of new drugs with novel targets to improve the current treatment of TB and to prevent the emergence of drug resistance in Mycobacterium tuberculosis. This review summarizes the anti-TB drug resistance mechanisms, furnishes some possible novel drug targets in the development of new agents for TB therapy and discusses the usefulness using known targets to develop new anti-TB drugs. Whole genome sequencing is currently an advanced technology to uncover drug resistance mechanisms in M. tuberculosis. However, further research is required to unravel the significance of some newly discovered gene mutations in their contribution to drug resistance.

AB - Drug-resistant tuberculosis (TB) poses a significant challenge to the successful treatment and control of TB worldwide. Resistance to anti-TB drugs has existed since the beginning of the chemotherapy era. New insights into the resistant mechanisms of anti-TB drugs have been provided. Better understanding of drug resistance mechanisms helps in the development of new tools for the rapid diagnosis of drug-resistant TB. There is also a pressing need in the development of new drugs with novel targets to improve the current treatment of TB and to prevent the emergence of drug resistance in Mycobacterium tuberculosis. This review summarizes the anti-TB drug resistance mechanisms, furnishes some possible novel drug targets in the development of new agents for TB therapy and discusses the usefulness using known targets to develop new anti-TB drugs. Whole genome sequencing is currently an advanced technology to uncover drug resistance mechanisms in M. tuberculosis. However, further research is required to unravel the significance of some newly discovered gene mutations in their contribution to drug resistance.

KW - Drug target

KW - Mechanism

KW - Mycobacterium tuberculosis

KW - Resistance

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85009108621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009108621&partnerID=8YFLogxK

U2 - 10.1016/j.jgg.2016.10.002

DO - 10.1016/j.jgg.2016.10.002

M3 - Review article

VL - 44

SP - 21

EP - 37

JO - Journal of Genetics and Genomics

T2 - Journal of Genetics and Genomics

JF - Journal of Genetics and Genomics

SN - 1673-8527

IS - 1

ER -

Access to Document